Fig. 4From: The consequences of implementing non-invasive prenatal testing with cell-free foetal DNA for the detection of Down syndrome in the Spanish National Health Service: a cost-effectiveness analysisDiagram representing the use of cffDNA-based NIPT as first-line testingBack to article page